eMedicine Specialties > Gastroenterology > Liver
Dubin-Johnson Syndrome: Treatment & Medication
Updated: May 19, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Medical Care
Dubin-Johnson syndrome (DJS) is a benign disorder and does not require any specific therapy. In the past, patients were treated with phenobarbital, which was primarily used to reduce serum bilirubin levels. This treatment is no longer recommended. Patients should be warned that pregnancy, oral contraceptive use, and intercurrent illness can exacerbate the icterus.
Drugs such as rifampicin and ursodeoxycholic acid (UDCA) should be used with caution in patients with Dubin-Johnson syndrome (DJS).
Corpechot et al reported the effects of chronic administration of rifampicin and UDCA in a patient with Dubin-Johnson syndrome (DJS) having a novel 974C→G nonsense mutation of the MRP2/ABCC2 gene.9 The adverse effects of these drugs on serum bilirubin and bile acid concentrations may result from an increased expression of MRP3 at the basolateral membrane of hepatocytes as a direct consequence of drug induction. This observation suggests that these drugs should be used with caution in situations in which MRP2 expression may be decreased, as observed in the late stage of cholestasis.9
More on Dubin-Johnson Syndrome |
| Overview: Dubin-Johnson Syndrome |
| Differential Diagnoses & Workup: Dubin-Johnson Syndrome |
Treatment & Medication: Dubin-Johnson Syndrome |
| Follow-up: Dubin-Johnson Syndrome |
| Multimedia: Dubin-Johnson Syndrome |
| References |
| Further Reading |
| « Previous Page | Next Page » |
References
Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. Jun 1997;25(6):1539-42. [Medline]. [Full Text].
Toh S, Wada M, Uchiumi T, et al. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet. Mar 1999;64(3):739-46. [Medline]. [Full Text].
Nisa AU, Ahmad Z. Dubin-Johnson syndrome. J Coll Physicians Surg Pak. Mar 2008;18(3):188-9. [Medline].
Zlotogora J. Hereditary disorders among Iranian Jews. Am J Med Genet. Jul 31 1995;58(1):32-7. [Medline].
Mor-Cohen R, Zivelin A, Fromovich-Amit Y, et al. Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations. Blood Coagul Fibrinolysis. Mar 2007;18(2):139-44. [Medline].
Bar-Meir S, Baron J, Seligson U, et al. 99mTc-HIDA cholescintigraphy in Dubin-Johnson and Rotor syndromes. Radiology. Mar 1982;142(3):743-6. [Medline]. [Full Text].
Zimniak P. Dubin-Johnson and Rotor syndromes: molecular basis and pathogenesis. Semin Liver Dis. Aug 1993;13(3):248-60. [Medline].
Sobaniec-Lotowska ME, Lebensztejn DM. Ultrastructure of Kupffer cells and hepatocytes in the Dubin-Johnson syndrome: a case report. World J Gastroenterol. Feb 14 2006;12(6):987-9. [Medline]. [Full Text].
Corpechot C, Ping C, Wendum D, et al. Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol. Oct 2006;101(10):2427-32. [Medline].
Bosia JD, D'Ascenzo MV, Borzi S, et al. [The Dubin-Johnson syndrome: case report and review of literature] [Spanish]. Acta Gastroenterol Latinoam. Sep 2008;38(3):194-8. [Medline].
Dubin IN. Chronic idiopathic jaundice; a review of fifty cases. Am J Med. Feb 1958;24(2):268-92. [Medline].
Fretzayas A, Kitsiou S, Papadopoulou A, Nicolaidou P. Clinical expression of co-inherited Dubin-Johnson and thalassaemic heterozygous states. Dig Liver Dis. Apr 2007;39(4):369-74. [Medline].
Jung MK, Bae MH, Kim DJ, et al. [A case with Rotor syndrome in hyperbilirubinemic family] [Korean]. Korean J Gastroenterol. Apr 2007;49(4):251-5. [Medline]. [Full Text].
Nowicki MJ, Poley JR. The hereditary hyperbilirubinaemias. Baillieres Clin Gastroenterol. Jun 1998;12(2):355-67. [Medline].
Rastogi A, Krishnani N, Pandey R. Dubin-Johnson syndrome--a clinicopathologic study of twenty cases. Indian J Pathol Microbiol. Oct 2006;49(4):500-4. [Medline].
Shani M, Seligsohn U, Gilon E, Sheba C, Adam A. Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med. Oct 1970;39(156):549-67. [Medline].
Sotelo-Avila C, Danis RK, Krafcik J, Malik M, Schwarz KB. Cholecystitis in a 17-year-old boy with recurrent jaundice since childhood. J Pediatr. Apr 1988;112(4):668-74. [Medline].
The familial conjugated hyperbilirubinemias. Semin Liver Dis. Nov 1994;14(4):386-94. [Medline].
Further Reading
Related eMedicine Topics
- Biliary Disease
- Cholestasis [in the Pediatrics: General Medicine section]
- Dubin-Johnson Syndrome [in the Pediatrics: General Medicine section]
- Factor VIII [in the Hematology section]
- Hyperbilirubinemia, Conjugated
- Hyperbilirubinemia, Unconjugated
- Jaundice, Neonatal [in the Pediatrics: Cardiac Disease and Critical Care Medicine section]
- Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
- Compassionate Use of Stanate (TM) [Stannsoporfin]
- Conjugated Hyperbilirubinemia and Pulse Oximetry
- Efficacy of High-Dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
- A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
- ACR Appropriateness Criteria® jaundice. American College of Radiology - Medical Specialty Society. 1996 (revised 2005). 6 pages. [NGC Update Pending] NGC:004626
- Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition - Professional Association. 2004 Aug. 14 pages. NGC:004185
- Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. American Academy of Pediatrics - Medical Specialty Society. 1994 Oct (revised 2004 Jul). 20 pages. NGC:003716
- Transcutaneous bilirubin testing. Laboratory medicine practice guidelines: evidence-based practice for point-of-care testing. National Academy of Clinical Biochemistry - Professional Association. 2006. 8 pages. NGC:005637
- United Kingdom national guideline on the management of the viral hepatitides A, B, and C 2005. British Association for Sexual Health and HIV - Medical Specialty Society. 1999 Aug (revised 2005). Various pagings. [NGC Update Pending] NGC:004513
- Viral hepatitis. Finnish Medical Society Duodecim - Professional Association. 2004 Dec 7 (revised 2008 Mar 10). Various pagings. NGC:006608
Keywords
Dubin-Johnson syndrome, DJS, hyperbilirubinemia, chronic idiopathic jaundice, neonatal jaundice, Gilbert syndrome, Crigler-Najjar syndrome, CNS, Rotor syndrome, Sprinz-Nelson syndrome
Treatment & Medication: Dubin-Johnson Syndrome